1. Home
  2. SNDA vs ORGO Comparison

SNDA vs ORGO Comparison

Compare SNDA & ORGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sonida Senior Living Inc.

SNDA

Sonida Senior Living Inc.

HOLD

Current Price

$32.55

Market Cap

501.8M

Sector

Health Care

ML Signal

HOLD

Logo Organogenesis Holdings Inc.

ORGO

Organogenesis Holdings Inc.

HOLD

Current Price

$5.06

Market Cap

539.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SNDA
ORGO
Founded
1990
1985
Country
United States
United States
Employees
N/A
N/A
Industry
Hospital/Nursing Management
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
501.8M
539.1M
IPO Year
1997
N/A

Fundamental Metrics

Financial Performance
Metric
SNDA
ORGO
Price
$32.55
$5.06
Analyst Decision
Hold
Buy
Analyst Count
1
3
Target Price
$28.00
$8.00
AVG Volume (30 Days)
65.0K
3.1M
Earning Date
11-10-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$327,007,000.00
$465,218,000.00
Revenue This Year
$25.63
$2.51
Revenue Next Year
$6.18
$25.45
P/E Ratio
N/A
N/A
Revenue Growth
29.15
2.24
52 Week Low
$19.34
$2.61
52 Week High
$33.50
$7.08

Technical Indicators

Market Signals
Indicator
SNDA
ORGO
Relative Strength Index (RSI) 66.51 48.85
Support Level $32.19 $5.09
Resistance Level $33.48 $5.83
Average True Range (ATR) 0.80 0.45
MACD -0.08 -0.10
Stochastic Oscillator 51.30 1.23

Price Performance

Historical Comparison
SNDA
ORGO

About SNDA Sonida Senior Living Inc.

Sonida Senior Living Inc is an owner operator of senior housing communities in the United States in terms of resident capacity. It provides senior living services to the elderly, including independent living, assisted living, Respite Care and Temporary Care Programs, Home Care Services, and memory care services. The company's objective is to provide value to residents by providing quality senior housing services at reasonable prices. The basic service of the company is comprised of meals, housekeeping, laundry, 24-hour staffing, transportation, social and recreational activities, and healthcare monitoring.

About ORGO Organogenesis Holdings Inc.

Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.

Share on Social Networks: